Cargando…

Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients

BACKGROUND: The poor prognosis and minimally successful treatments of malignant glioma indicate a challenge to identify new therapeutic targets which impact glioma progression. Neurotensin (NTS) and its high affinity receptor (NTSR1) overexpression induces neoplastic growth and predicts the poor pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouyang, Qing, Gong, Xueyang, Xiao, Hualiang, Zhou, Ji, Xu, Minhui, Dai, Yun, Xu, Lunshan, Feng, Hua, Cui, Hongjuan, Yi, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351837/ https://www.ncbi.nlm.nih.gov/pubmed/25644759 http://dx.doi.org/10.1186/s12943-015-0290-8

Ejemplares similares

Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients
por: Ouyang, Qing, et al.
Publicado: (2022)

Increased Brain Neurotensin and NTSR2 Lead to Weak Nociception in NTSR3/Sortilin Knockout Mice
por: Devader, Christelle, et al.
Publicado: (2016)

Neurotensin Receptor 1 Gene (NTSR1) Polymorphism Is Associated with Working Memory
por: Li, Jin, et al.
Publicado: (2011)

Downregulation of miR-16 via URGCP pathway contributes to glioma growth
por: Hong, Liang, et al.
Publicado: (2017)

Mutant-allele tumor heterogeneity in malignant glioma effectively predicts neoplastic recurrence
por: Wu, Pengfei, et al.
Publicado: (2019)

Prediction of Cancer-Specific Survival of Brainstem Glioma in Children Based on Risk Stratification Model
por: Sun, Kai, et al.
Publicado: (2022)

Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib
por: Younes, Mohamad, et al.
Publicado: (2014)

TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients
por: Wang, Chao, et al.
Publicado: (2010)

14-3-3β exerts glioma-promoting effects and is associated with malignant progression and poor prognosis in patients with glioma
por: Liu, Liang, et al.
Publicado: (2018)

MicroRNAs in the Diagnosis of Malignancy of Supratentorial Brain Gliomas and Prognosis of Disease Progression
por: Stupak, Evgeny V, et al.
Publicado: (2023)

Correlation of microrna-372 upregulation with poor prognosis in human glioma
por: Li, Gang, et al.
Publicado: (2013)

Isolation and Characterization of Fast-Migrating Human Glioma Cells in the Progression of Malignant Gliomas
por: Adamski, Vivian, et al.
Publicado: (2017)

HSPA6 is Correlated With the Malignant Progression and Immune Microenvironment of Gliomas
por: Zhou, Xiang, et al.
Publicado: (2022)

Progress on Antiangiogenic Therapy for Patients with Malignant Glioma
por: Ahluwalia, Manmeet S., et al.
Publicado: (2010)

Vasorin stimulates malignant progression and angiogenesis in glioma
por: Liang, Weiye, et al.
Publicado: (2019)

Secretory Pathway Kinase FAM20C, a Marker for Glioma Invasion and Malignancy, Predicts Poor Prognosis of Glioma
por: Du, Shaonan, et al.
Publicado: (2020)

Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors
por: Kamimae, Seiko, et al.
Publicado: (2015)

AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma
por: Zhao, Zijin, et al.
Publicado: (2017)

Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment
por: Li, Yong, et al.
Publicado: (2020)

Phosphorylated SATB1 is associated with the progression and prognosis of glioma
por: Han, S, et al.
Publicado: (2013)

Polycomb group expression signatures in the malignant progression of gliomas
por: Hu, Qi, et al.
Publicado: (2017)

CX3CR1 and malignant progression of glioma
por: Lee, Sungho, et al.
Publicado: (2021)

Malignant Progression of an IDH Mutant Brainstem Glioma in Adult
por: SANO, Kenshi, et al.
Publicado: (2021)

Targeting FGL2 in glioma immunosuppression and malignant progression
por: Ma, Xiaoyu, et al.
Publicado: (2022)

NTSR1 glycosylation and MMP dependent cleavage generate three distinct forms of the protein
por: Libanje, Fotine, et al.
Publicado: (2023)

Glioma Stem Cells and Immunotherapy for the Treatment of Malignant Gliomas
por: Toda, Masahiro
Publicado: (2013)

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

Immunotherapy for malignant glioma
por: Suryadevara, Carter M., et al.
Publicado: (2015)

Immunotherapies for Malignant Glioma
por: Boussiotis, Vassiliki A., et al.
Publicado: (2017)

Competing Endogenous RNA Networks in Glioma
por: Cen, Liang, et al.
Publicado: (2021)

MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis
por: Yan, Wei, et al.
Publicado: (2014)

Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
por: Teng, Chubei, et al.
Publicado: (2022)

LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis
por: Chen, Yi-Ling, et al.
Publicado: (2023)

ET-8 Integrated diagnostic approach to predict prognosis for malignant gliomas
por: Isoda, Masataka, et al.
Publicado: (2021)

The expression of Hexokinase 2 and its hub genes are correlated with the prognosis in glioma
por: Huang, Yishan, et al.
Publicado: (2022)

Decreased expression of LATS1 is correlated with the progression and prognosis of glioma
por: Ji, Tianhai, et al.
Publicado: (2012)

Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas
por: Martinho, Olga, et al.
Publicado: (2012)

DNA demethylation is associated with malignant progression of lower-grade gliomas
por: Nomura, Masashi, et al.
Publicado: (2019)

Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas
por: Zhao, Zheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jqm7fb6k10u4jlc44kedbr44aj